Harper Molly (CIK 0001871470)

Latest company ownership

Shares held
8,640
Last filed at
Nov 24, 2025
Confidence Score
27.4
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 12, 2025 Dec 16, 2025 CATALYST PHARMACEUTICALS, INC. Director Sell 20.0 -26,746 -91.89% $621.9K
Nov 27, 2024 Nov 29, 2024 CATALYST PHARMACEUTICALS, INC. Director Sell 20.0 -17,500 -100.00% $385K
Jun 3, 2024 Jun 5, 2024 CATALYST PHARMACEUTICALS, INC. Director Sell 22.5 -5,333 -100.00% $86.9K
Dec 15, 2023 Dec 19, 2023 CATALYST PHARMACEUTICALS, INC. Director Sell 22.5 -14,000 -100.00% $201.4K